G-5555
目录号: PL08764 纯度: ≥99%
CAS No. :1648863-90-4
商品编号 规格 价格 会员价 是否有货 数量
PL08764-5mg 5mg ¥1360.00 请登录
PL08764-10mg 10mg ¥1978.18 请登录
PL08764-25mg 25mg ¥4450.91 请登录
PL08764-50mg 50mg ¥7912.73 请登录
PL08764-100mg 100mg ¥13600.00 请登录
PL08764-200mg 200mg 询价 询价
PL08764-500mg 500mg 询价 询价
PL08764-10mM*1mLinDMSO 10mM*1mLinDMSO ¥1471.27 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
G-5555
中文别名
G-5555
英文名称
G-5555
英文别名
G-5555;G5555;G-5555 hydrochloride
Cas No.
1648863-90-4
分子式
C25H26Cl2N6O3
分子量
529.42
包装储存
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
产品详情
G-5555 是有效 PAK1 抑制剂,对 PAK1 和 PAK2 的 Ki 值分别为 3.7 nM 和 11 nM。
生物活性
G-5555 is a potent p21-activated kinase 1 (PAK1) inhibitor with K i s of 3.7 nM and 11 nM for PAK1 and PAK2, respectively.
性状
Solid
IC50 & Target[1][2]
PAK1 3.7 nM (Ki) PAK2 11 nM (Ki)
体外研究(In Vitro)
G-5555 is a potent PAK1 inhibitor with a Ki of 3.7 nM. G-5555 shows excellent kinase selectivity and inhibits only eight out of the 235 kinases tested other than PAK1 with inhibition >70%: PAK2, PAK3, KHS1, Lck, MST3, MST4, SIK2, and YSK1. The IC50s of G-5555 against SIK2, PAK2, KHS1, MST4, YSK1, MST3 and Lck are 9, 11, 10, 20, 34, 43, 52 nM, respectively. In general, G-5555 demonstrates high selectivity for the group I PAKs. There is negligible activity for G-5555 against the hERG channel with IC50 more than 10 μM in a patch clamp assay. G-5555 potently inhibits PAK2, with a Ki of 11 nM. In an array of 23 breast cancer cell lines, G-5555 has significantly greater growth inhibitory activity in cell lines that are PAK-amplified compared to non-amplified lines. has not indepe
体内研究(In Vivo)
G-5555 exhibits low blood clearance and an acceptable half-life. Good oral exposure (AUC = 30 μM?h) and high oral bioavailability (F = 80%) are achieved. In an H292 non-small cell lunger cancer (NSCLC) xenograft study in mice, G-5555 inhibits phosphorylation of the PAK1/2 downstream substrate mitogen-activated protein kinase 1 (MEK1) S298 and, when administered at an oral dose of 25 mg/kg b.i.d., imparts 60% tumor growth inhibition in this model13 and a PAK1 amplified breast cancer xenograft model, MDAMB-175. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
参考文献
[1]. Ndubaku CO, et al. Design of Selective PAK1 Inhibitor G-5555: Improving Properties by Employing an Unorthodox Low-pK a Polar Moiety. ACS Med Chem Lett. 2015 Oct 31;6(12):1241-6.
[2]. Rudolph J, et al. Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic Window. J Med Chem. 2016 Jun 9;59(11):5520-41.
溶解度数据
In Vitro: DMSO : 25 mg/mL (50.71 mM; ultrasonic and warming and heat to 80°C)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2